한글목차

세계 주입형 골이식 시장 규모는 2023년 6억 7,413만 달러에 달했습니다.

이 시장은 2024-2030년 예측 기간 동안 5.15%의 CAGR로 성장하여 2030년까지 9억 5,206만 달러에 달할 것으로 예상됩니다.

북미의 주입형 골이식 시장 규모는 2023년 5억 94만 달러에 달했습니다. 이 시장은 2024-2030년 예측 기간 동안 5.20%의 CAGR로 성장하여 2030년까지 7억 796만 달러에 달할 것으로 예상됩니다.

유럽의 주입형 골이식 시장 규모는 2023년 1억 2,175만 달러에 달했습니다. 이 시장은 2024-2030년 예측 기간 동안 4.76%의 CAGR로 성장하여 2030년에는 1억 6,906만 달러에 달할 것으로 예상됩니다.

세계 병원용 주입형 골이식 시장 규모는 2023년 4억 4,568만 달러에 달했습니다. 이 시장은 2024-2030년 예측 기간 동안 5.13%의 CAGR로 성장하여 2030년까지 6억 2,526만 달러에 달할 것으로 예상됩니다.

주입형 골이식 분야의 주요 세계 기업으로는 Medtronic, DePuy Synthes, Baxter, Stryker(Wright Medical), BONESUPPORT, Xtant Medical, SeaSpine, Zimmer Biomet, Biocomposites 등이 있으며, 2023년 세계 상위 3개 업체가 매출의 약 43.09%를 차지했습니다.

이 보고서는 세계 주입형 골이식 시장을 조사하여 시장 개요와 함께 유형별, 용도별, 지역별 동향, 시장 진입 기업 개요 등을 제공합니다.

목차

제1장 보고서 개요

• 조사 범위
• 유형별 시장 분석
• 용도별 시장
• 가정과 제한
• 조사 목적
• 대상 연도

제2장 세계의 성장 동향

• 세계의 주입형 골이식 시장 전망(2019-2030년)
• 세계의 골이식 주사 성장 동향, 지역별
• 주입형 골이식 시장 역학

제3장 주요 진출 기업에 의한 경쟁 상황

제4장 주입형 골이식 내역 데이터, 유형별

• 세계의 주입형 골이식 시장 규모 실적(유형별)(2019-2024년)
• 세계의 주입형 골이식 시장 규모 예측(유형별)(2025-2030년)

제5장 주입형 골이식 내역 데이터, 용도별

• 세계의 주입형 골이식 시장 규모 실적(용도별)(2019-2024년)
• 세계의 주입형 골이식 시장 규모 예측(용도별)(2025-2030년)

제6장 북미

제7장 유럽

제8장 아시아태평양

제9장 라틴아메리카

제10장 중동 및 아프리카

제11장 주요 기업 개요

• Medtronic
• DePuy Synthes
• Baxter
• Stryker(Wright Medical)
• BONESUPPORT
• Xtant Medical
• SeaSpine
• Zimmer Biomet
• Biocomposites
• Anika
• ORD
• Biomatlante
• Graftys

제12장 산업 체인과 판매 채널 분석

제13장 애널리스트의 견해/결론

제14장 부록

영문목차

The global Injectable Bone Graft market was valued at US$ 674.13 million in 2023 and is anticipated to reach US$ 952.06 million by 2030, witnessing a CAGR of 5.15% during the forecast period 2024-2030.

North American market for Injectable Bone Graft is estimated to increase from $ 500.94 million in 2023 to reach $ 707.96 million by 2030, at a CAGR of 5.20% during the forecast period of 2024 through 2030.

Europe market for Injectable Bone Graft is estimated to increase from $ 121.75 million in 2023 to reach $169.06 million by 2030, at a CAGR of 4.76% during the forecast period of 2024 through 2030.

The global market for Injectable Bone Graft in Hospital is estimated to increase from $ 445.68 million in 2023 to $ 625.26 million by 2030, at a CAGR of 5.13% during the forecast period of 2024 through 2030.

The major global companies of Injectable Bone Graft include Medtronic, DePuy Synthes, Baxter, Stryker (Wright Medical), BONESUPPORT, Xtant Medical, SeaSpine, Zimmer Biomet, and Biocomposites, etc. In 2023, the world's top three vendors accounted for approximately 43.09% of the revenue.

This report aims to provide a comprehensive presentation of the global market for Injectable Bone Graft, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable Bone Graft.

The Injectable Bone Graft market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Injectable Bone Graft market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Injectable Bone Graft companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

• Medtronic
• DePuy Synthes
• Baxter
• Stryker (Wright Medical)
• BONESUPPORT
• Xtant Medical
• SeaSpine
• Zimmer Biomet
• Biocomposites
• Anika
• ORD
• Biomatlante
• Graftys

Segment by Type

• Synthetic
• Natural

Segment by Application

• Hospital
• Clinic

By Region

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• South Korea
• Southeast Asia
• India
• Australia
• Rest of Asia
• Europe
• Germany
• France
• U.K.
• Italy
• Rest of Europe
• South America
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Middle East & Africa
• Turkey
• Saudi Arabia
• UAE
• Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Injectable Bone Graft company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Injectable Bone Graft Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
  • 1.2.2 Synthetic
  • 1.2.3 Natural
• 1.3 Market by Application
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Injectable Bone Graft Market Perspective (2019-2030)
• 2.2 Global Injectable Bone Graft Growth Trends by Region
  • 2.2.1 Global Injectable Bone Graft Market Size by Region: 2019 VS 2023 VS 2030
  • 2.2.2 Injectable Bone Graft Historic Market Size by Region (2019-2024)
  • 2.2.3 Injectable Bone Graft Forecasted Market Size by Region (2025-2030)
• 2.3 Injectable Bone Graft Market Dynamics
  • 2.3.1 Injectable Bone Graft Industry Trends
  • 2.3.2 Injectable Bone Graft Market Drivers
  • 2.3.3 Injectable Bone Graft Market Challenges
  • 2.3.4 Injectable Bone Graft Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Injectable Bone Graft Players by Revenue
  • 3.1.1 Global Top Injectable Bone Graft Players by Revenue (2019-2024)
  • 3.1.2 Global Injectable Bone Graft Revenue Market Share by Players (2019-2024)
• 3.2 Global Injectable Bone Graft Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Global Injectable Bone Graft Market Concentration Ratio
  • 3.3.1 Global Injectable Bone Graft Market Concentration Ratio (CR5)
  • 3.3.2 Global Top 10 and Top 5 Companies by Injectable Bone Graft Revenue in 2023
• 3.4 Global Key Players of Injectable Bone Graft Head office and Area Served
• 3.5 Global Key Players of Injectable Bone Graft, Product and Application
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Injectable Bone Graft Breakdown Data by Type

• 4.1 Global Injectable Bone Graft Historic Market Size by Type (2019-2024)
• 4.2 Global Injectable Bone Graft Forecasted Market Size by Type (2025-2030)

5 Injectable Bone Graft Breakdown Data by Application

• 5.1 Global Injectable Bone Graft Historic Market Size by Application (2019-2024)
• 5.2 Global Injectable Bone Graft Forecasted Market Size by Application (2025-2030)

6 North America

• 6.1 North America Injectable Bone Graft Market Size (2019-2030)
• 6.2 North America Injectable Bone Graft Market Growth Rate by Country: 2019 VS 2023 VS 2030
• 6.3 North America Injectable Bone Graft Market Size by Country (2019-2024)
• 6.4 North America Injectable Bone Graft Market Size by Country (2025-2030)
• 6.5 United States
• 6.6 Canada

7 Europe

• 7.1 Europe Injectable Bone Graft Market Size (2019-2030)
• 7.2 Europe Injectable Bone Graft Market Growth Rate by Country: 2019 VS 2023 VS 2030
• 7.3 Europe Injectable Bone Graft Market Size by Country (2019-2024)
• 7.4 Europe Injectable Bone Graft Market Size by Country (2025-2030)
• 7.5 Germany
• 7.6 France
• 7.7 U.K.
• 7.8 Italy

8 Asia-Pacific

• 8.1 Asia-Pacific Injectable Bone Graft Market Size (2019-2030)
• 8.2 Asia-Pacific Injectable Bone Graft Market Growth Rate by Country: 2019 VS 2023 VS 2030
• 8.3 Asia-Pacific Injectable Bone Graft Market Size by Region (2019-2024)
• 8.4 Asia-Pacific Injectable Bone Graft Market Size by Region (2025-2030)
• 8.5 China
• 8.6 Japan
• 8.7 South Korea
• 8.8 Southeast Asia
• 8.9 India
• 8.10 Australia

9 Latin America

• 9.1 Latin America Injectable Bone Graft Market Size (2019-2030)
• 9.2 Latin America Injectable Bone Graft Market Growth Rate by Country: 2019 VS 2023 VS 2030
• 9.3 Latin America Injectable Bone Graft Market Size by Country (2019-2024)
• 9.4 Latin America Injectable Bone Graft Market Size by Country (2025-2030)
• 9.5 Brazil
• 9.6 Mexico
• 9.7 Argentina

10 Middle East & Africa

• 10.1 Middle East & Africa Injectable Bone Graft Market Size (2019-2030)
• 10.2 Middle East & Africa Injectable Bone Graft Market Growth Rate by Country: 2019 VS 2023 VS 2030
• 10.3 Middle East & Africa Injectable Bone Graft Market Size by Country (2019-2024)
• 10.4 Middle East & Africa Injectable Bone Graft Market Size by Country (2025-2030)
• 10.5 Turkey
• 10.6 Saudi Arabia
• 10.7 UAE

11 Key Players Profiles

• 11.1 Medtronic
  • 11.1.1 Medtronic Company Details
  • 11.1.2 Medtronic Business Overview
  • 11.1.3 Medtronic Injectable Bone Graft Introduction
  • 11.1.4 Medtronic Revenue in Injectable Bone Graft Business (2019-2024)
• 11.2 DePuy Synthes
  • 11.2.1 DePuy Synthes Company Details
  • 11.2.2 DePuy Synthes Business Overview
  • 11.2.3 DePuy Synthes Injectable Bone Graft Introduction
  • 11.2.4 DePuy Synthes Revenue in Injectable Bone Graft Business (2019-2024)
• 11.3 Baxter
  • 11.3.1 Baxter Company Details
  • 11.3.2 Baxter Business Overview
  • 11.3.3 Baxter Injectable Bone Graft Introduction
  • 11.3.4 Baxter Revenue in Injectable Bone Graft Business (2019-2024)
• 11.4 Stryker (Wright Medical)
  • 11.4.1 Stryker (Wright Medical) Company Details
  • 11.4.2 Stryker (Wright Medical) Business Overview
  • 11.4.3 Stryker (Wright Medical) Injectable Bone Graft Introduction
  • 11.4.4 Stryker (Wright Medical) Revenue in Injectable Bone Graft Business (2019-2024)
• 11.5 BONESUPPORT
  • 11.5.1 BONESUPPORT Company Details
  • 11.5.2 BONESUPPORT Business Overview
  • 11.5.3 BONESUPPORT Injectable Bone Graft Introduction
  • 11.5.4 BONESUPPORT Revenue in Injectable Bone Graft Business (2019-2024)
• 11.6 Xtant Medical
  • 11.6.1 Xtant Medical Company Details
  • 11.6.2 Xtant Medical Business Overview
  • 11.6.3 Xtant Medical Injectable Bone Graft Introduction
  • 11.6.4 Xtant Medical Revenue in Injectable Bone Graft Business (2019-2024)
• 11.7 SeaSpine
  • 11.7.1 SeaSpine Company Details
  • 11.7.2 SeaSpine Business Overview
  • 11.7.3 SeaSpine Injectable Bone Graft Introduction
  • 11.7.4 SeaSpine Revenue in Injectable Bone Graft Business (2019-2024)
• 11.8 Zimmer Biomet
  • 11.8.1 Zimmer Biomet Company Details
  • 11.8.2 Zimmer Biomet Business Overview
  • 11.8.3 Zimmer Biomet Injectable Bone Graft Introduction
  • 11.8.4 Zimmer Biomet Revenue in Injectable Bone Graft Business (2019-2024)
• 11.9 Biocomposites
  • 11.9.1 Biocomposites Company Details
  • 11.9.2 Biocomposites Business Overview
  • 11.9.3 Biocomposites Injectable Bone Graft Introduction
  • 11.9.4 Biocomposites Revenue in Injectable Bone Graft Business (2019-2024)
• 11.10 Anika
  • 11.10.1 Anika Company Details
  • 11.10.2 Anika Business Overview
  • 11.10.3 Anika Injectable Bone Graft Introduction
  • 11.10.4 Anika Revenue in Injectable Bone Graft Business (2019-2024)
• 11.11 ORD
  • 11.11.1 ORD Company Details
  • 11.11.2 ORD Business Overview
  • 11.11.3 ORD Injectable Bone Graft Introduction
  • 11.11.4 ORD Revenue in Injectable Bone Graft Business (2019-2024)
• 11.12 Biomatlante
  • 11.12.1 Biomatlante Company Details
  • 11.12.2 Biomatlante Business Overview
  • 11.12.3 Biomatlante Injectable Bone Graft Introduction
  • 11.12.4 Biomatlante Revenue in Injectable Bone Graft Business (2019-2024)
• 11.13 Graftys
  • 11.13.1 Graftys Company Details
  • 11.13.2 Graftys Business Overview
  • 11.13.3 Graftys Injectable Bone Graft Introduction
  • 11.13.4 Graftys Revenue in Injectable Bone Graft Business (2019-2024)

12 Industry Chain and Sales Channels Analysis

• 12.1 Injectable Bone Graft Industry Chain Analysis
• 12.2 Injectable Bone Graft Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Injectable Bone Graft Production Mode & Process
• 12.4 Injectable Bone Graft Sales and Marketing
  • 12.4.1 Injectable Bone Graft Sales Channels
  • 12.4.2 Injectable Bone Graft Distributors

13 Analyst's Viewpoints/Conclusions

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
  • 14.1.2 Data Source
• 14.2 Author Details
• 14.3 Disclaimer